RTW INVESTMENTS, LP - BIOPHARMX CORP ownership

BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 14 filers reported holding BIOPHARMX CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of BIOPHARMX CORP
ValueSharesWeighting
Q1 2017$648,000
+36.1%
1,283,951
+0.9%
0.17%
-4.5%
Q4 2016$476,000
+22.4%
1,273,128
+81.7%
0.18%
+51.7%
Q3 2016$389,000
-14.5%
700,6360.0%0.12%
-23.9%
Q2 2016$455,000
-40.4%
700,6360.0%0.16%
-44.0%
Q1 2016$764,000
+35.7%
700,636
+89.0%
0.28%
+48.9%
Q4 2015$563,000
+47.4%
370,6360.0%0.19%
+56.3%
Q3 2015$382,000
-59.7%
370,6360.0%0.12%
-56.9%
Q2 2015$949,000370,6360.28%
Other shareholders
BIOPHARMX CORP shareholders Q2 2016
NameSharesValueWeighting ↓
Vivo Capital, LLC 12,814,286$6,471,0001.90%
RTW INVESTMENTS, LP 1,283,951$648,0000.17%
Sio Capital Management, LLC 313,717$158,0000.09%
DAFNA Capital Management LLC 115,000$58,0000.05%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 28,027$14,0000.00%
Baker Brothers Advisors 377,295$191,0000.00%
Virtu KCG Holdings LLC 107,994$55,0000.00%
FRANKLIN RESOURCES INC 9,499,615$4,797,0000.00%
Moors & Cabot, Inc. 13,000$7,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 17,274$8,0000.00%
View complete list of BIOPHARMX CORP shareholders